Bioavailability study of Vitamin K2

An open label single oral dose bioavailability study of vitamin K2-7 (capsules 1000microgm) of Synergia Lifesciences Pvt.Ltd in Healthy adult, human subjects

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009660

Enrollment

Registered

2017-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Vitamin K 2-7 (1000 microgram): Naturally occurring Vitamin K analogue Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Volunteers

Exclusion criteria

Exclusion criteria: Hypersensitivity to vitamin K and consumption of fermented food in last 24 hours

Design outcomes

Primary

Measure	Time frame
Evaluation of Bioavailability and pharmacokinetic profile of test drugTimepoint: After study completion	—

Secondary

Measure	Time frame
Safety of the test drugTimepoint: Throughout the study	—

Countries

India

Contacts

Public ContactDrNithya Gogtay

Seth GSMC and KEM hospital

njgogtay@hotmail.com02224133767

Outcome results